Design Considerations for using PET as a Response Measure in Single Site and Multicenter Clinical Trials

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

Medicine, Oncology, Treatment Planning +14

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations

Helen Young, R. Baum, U. Cremerius et al. · European Journal of Cancer · 1999 · 1.7K citations · Full text

Medicine, Oncology, Radiology +16

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Lalitha Shankar, John M. Hoffman, S.L. Bacharach et al. · PubMed · 2006 · 679 citations

Medicine, Nuclear Medicine, Oncology +17

Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.

Kenneth Zasadny, Richard L. Wahl · Radiology · 1993 · 638 citations

Medicine, Nuclear Medicine, Oncology +15

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.

Richard L. Wahl, Kenneth Zasadny, Mark A. Helvie et al. · Journal of Clinical Oncology · 1993 · 612 citations

Medicine, Nuclear Medicine, Oncology +17